Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$82.37 - $107.29 $2.39 Million - $3.11 Million
29,000 New
29,000 $2.4 Million
Q1 2020

May 14, 2020

SELL
$52.41 - $81.0 $733,740 - $1.13 Million
-14,000 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$71.7 - $82.09 $430,200 - $492,540
6,000 Added 75.0%
14,000 $3.27 Million
Q3 2019

Nov 14, 2019

BUY
$61.55 - $75.43 $492,400 - $603,440
8,000 New
8,000 $1.76 Million

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $41.9B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Atika Capital Management LLC Portfolio

Follow Atika Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Atika Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Atika Capital Management LLC with notifications on news.